MLL1 anticorps
Aperçu rapide pour MLL1 anticorps (ABIN6952424)
Antigène
Voir toutes MLL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Specificité
- Polyclonal antibody raised in rabbit against human MLL1 (Mixed-Lineage Leukemia) using two KLH-conjugated synthetic peptides containing a sequence from the central region of the protein.
-
Purification
- whole antiserum
-
Immunogène
- synthetic peptide
-
-
-
-
Indications d'application
-
ChIP/ChIP-seq 2 μL:ChIP
ELISA 1:100 - 1:1,000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- serum, 0.05 % azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- MLL1 (Myeloid/lymphoid Or Mixed-Lineage Leukemia 1 (MLL1))
-
Autre désignation
- MLL1
-
Sujet
- MLL1 (UniProtKB/Swiss-Prot entry Q03164) functions as a lysine methyltransferase responsible for the methylation of H3K4 which is associated with epigenetic transcriptional activation. MLL1 regulates the transcription of specific target genes, including many of the HOX genes and plays an essential role in regulating gene expression during early development and hematopoiesis. It also plays a role in the control of circadian gene expression. Mll1 is involved in several translocations which cause certain acute lymphoid leukemias and acute myeloid leukemias.
-
UniProt
- Q03164
Antigène
-